Consumers Report Serious and Life-Threatening Complications
Ozempic, Wegovy, and Mounjaro, all using semaglutide medications developed for type 2 diabetes, gained widespread popularity due to their notable weight loss effects. Novo Nordisk, the manufacturer of Ozempic and Wegovy, saw this potential and developed Wegovy, a higher-dose version, which was approved by the FDA specifically for weight loss. Following an aggressive marketing campaign, both Wegovy and Mounjaro, a similar drug by Eli Lilly, surged in popularity.
However, recent litigation has raised serious concerns about the safety of these drugs. Numerous lawsuits have been filed against Novo Nordisk, Eli Lilly, and other pharmaceutical companies, claiming that the medications cause severe gastrointestinal complications such as gastroparesis, stomach paralysis, and ileus. Plaintiffs allege that these companies failed to adequately warn consumers about these risks, which can lead to lifelong medical challenges. There are also reports of vision loss and other serious complications.
If you or a loved one has experienced severe gastrointestinal issues after using these or similar diabetes drugs, you may be entitled to compensation. At Cohen & Malad, LLP, we represent clients across the country who have been harmed by pharmaceutical drugs and medical devices. Our experienced product liability and personal injury attorneys are committed to holding manufacturers accountable for the harm caused by their products.
Call or message Cohen & Malad, LLP today for a free case evaluation. Our legal team will help you explore your legal options and fight for the compensation you deserve.
